Calcitonin receptor antibodies in the identification of osteoclasts

Bone

Volumn 25, Issue 1, 1999, Pages 1-8

  Quinn, J M W ^a   Morfis, M ^b   Lam, M H C ^a   Elliott, J ^a   Kartsogiannis, V ^a   Williams, E D ^a   Gillespie, M T ^a   Martin, T J ^a   Sexton, P M ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone; Calcitonin receptor; F4 80 antigen; Immunohistochemistry; Osteoclast; Polyclonal antibody

Indexed keywords

CALCITONIN RECEPTOR; DIHYDROXYCOLECALCIFEROL; IODINE 125; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTAGLANDIN E2; SALCATONIN;

ABSORPTION; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTORADIOGRAPHY; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; COCULTURE; CONTROLLED STUDY; GENETIC RECOMBINATION; GENETIC STABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN DOMAIN; RABBIT; RAT; SPLEEN CELL;

EID: 0033061568     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00094-0     Document Type: Article

References (50)

1. 2+ mobilization and cell retraction . J Endocrinol. 136:1993;7-15.
2. Athanasou N.A. Cellular biology of bone-resorbing cells. J Bone Joint Surg (A). 78:1996;1096-1112.
3. Athanasou N.A., Alvarez J.I., Ross F.P., Quinn J.M., Teitelbaum S.L. Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes. Calcif Tissue Int. 50:1992;427-432.
4. Athanasou N.A., Quinn J. Immunophenotypic differences between osteoclasts and macrophage polykaryons immunohistological distinction and implications for osteoclast ontogeny and function . J Clin Pathol. 43:1990;997-1003.
5. Athanasou N.A., Quinn J.M., Horton M.A., McGee J.O. New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Miner. 8:1990;7-22.
6. Austyn J.M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 11:1981;805-815.
7. Bevilacqua M.A., Lord D.K., Cross N.C., Whitaker K.B., Moss D.W., Cox T.M. Regulation and expression of type V (tartrate-resistant) acid phosphatase in human mononuclear phagocytes. Mol Biol Med. 8:1991;135-140.
8. Cammer W., Zhang H. Carbonic anhydrase II in microglia in forebrains of neonatal rats. J Neuroimmunol. 67:1996;131-136.
9. Chambers T.J., McSheehy P.M.J., Thompson B.M., Fuller K. The effects of calcium regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 116:1985;234-239.
10. Chambers T.J., Owens J.M., Hattersley G., Jat P.S., Noble M.D. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA. 90:1993;5578-5582.
11. Chambers T.J., Revell P.A., Fuller K., Athanasou N.A. Resorption of bone by isolated rabbit osteoclasts. J Cell Sci. 66:1984;383-399.
12. Chatterjee D., Chakraborty M., Leit M., et al. Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar vacuolar H(+)-ATPases. J Exp Biol. 172:1992;193-204.
13. Dodds R.A., Connor J.R., Drake F., Feild J., Gowen M. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J Bone Miner Res. 13:1998;673-682.
14. Domon T., Wakita M. Electron microscopic and histochemical studies of the mononuclear osteoclast of the mouse. Am J Anat. 192:1991;35-44.
15. Doussis I.A., Puddle B., Athanasou N.A. Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. J Clin Pathol. 45:1992;398-404.
16. Goldring S.R. The structure and molecular biology of the calcitonin receptor. Bilezikian J.P., Raisz L.C., Rodan G.A. Principles of bone biology. 1996;461-470 Academic, San Diego, CA.
17. Gravallese E.M., Harada Y., Wang J.T., Gorn A.H., Thornhill T.S., Goldring S.R. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 152:1998;943-951.
18. Hattersley G., Chambers T.J. Generation of osteoclastic function in mouse bone marrow cultures multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclast differentiation . Endocrinology. 124:1989;1689-1695.
19. Hattersley G., Chambers T.J. Calcitonin receptors as markers for osteoclastic differentiation correlation between generation of bone resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures . Endocrinology. 125:1989;1606-1612.
20. Horton M.A., Lewis D., McNulty K., Pringle J.A.S., Chambers T.J. Monoclonal antibodies to osteoclastomas (giant cell bone tumors) identification of osteoclast-specific antigens . Cancer Res. 45:1985;5663-5669.
21. Houssami S., Findlay D.M., Brady C.L., Myers D.E., Martin T.J., Sexton P.M. Isoforms of the rat calcitonin receptor consequences for ligand binding and signal transduction . Endocrinology. 135:1994;183-190.
22. Hume D.A., Loutit J.F., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of the antigen F4/80 in macrophages of bone and associated connective tissue. J Cell Sci. 66:1984;189-194.
23. Ikegame M., Rakopoulos M., Zhou H., et al. Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res. 10:1995;59-65.
24. Iotsova V., Caamano J., Loy J., Lewin A., Bravo R. Ostepetrosis in mice lacking NF-kappa B1 and NF-kappa B2. Nature Med. 3:1997;1285-1289.
25. Kuestner R.E., Elrod R., Grant F.J., et al. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacology. 46:1994;246-255.
26. Laemmli U.K. Cleavage of proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Lee S.K., Goldring S.R., Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone a specific marker of the differentiated osteoclast that is regulated by calcitonin . Endocrinology. 136:1995;4572-4581.
28. Lin H.Y., Harris T.L., Flannery M.S., et al. Expression cloning of an adenylate cyclase-coupled calsitonin receptor. Science. 254:1991;1022-1024.
29. Littlewood-Evans A.J., Bilbe G., Bowler W.B., et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57:1997;5386-5390.
30. Littlewood-Evans A.J., Kokubo T., Ishibashi O., et al. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20:1997;81-86.
31. Lomri A., Baron R. 1 alpha,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes. Proc Natl Acad Sci USA. 89:1992;4688-4692.
32. Marks S.C. Jr, Popoff S.N. Bone cell biology the regulation of development, structure, and function in the skeleton . Am J Anat. 183:1988;1-44.
33. Martin T.J., Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 56:1994;357-366.
34. Minkin C. Bone and phosphatase tartrate-resistant phosphatase as a marker of osteoclast function . Calcif Tissue Int. 34:1982;285-290.
35. Modderman W.E., Tuinenberg Bol-Raap A.C., Nijweide P.J. Tartrate-resistant acid phosphatase is not an exclusive marker for mouse osteoclasts in cell culture. Bone. 12:1991;81-87.
36. Nicholson G.C., Mosely J.M., Sexton P.M., Mendelsohn F.A.O., Martin T.J. Abundant calcitonin on isolated osteoclasts Biochemical and autoradiographic characterization . J Clin Invest. 78:1986;355-360.
37. Perry K.J., Quiza M., Myers D.E., Morfis M., Christopoulos G., Sexton P.M. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line. Endocrinology. 138:1997;3486-3496.
38. Quinn J.M.W., Elliott J., Gillespie M.T., Martin T.J. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology. 139:1998;4424-4427.
39. Quinn J.M.W., McGee J.O'D., Athanasou N.A. Cellular and hormonal factors influencing monocyte differentiation in osteoclastic bone-resorbing cells. Endocrinology. 134:1994;2416-2423.
40. Stern M., Savill J., Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response . Am J Pathol. 149:1996;911-921.
41. Stroop S.D., Kuestner R.E., Serwold T.F., Chen L., Moore E.E. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry. 34:1995;1050-1057.
42. Suda T., Udagawa N., Takahashi N. Cells of bone osteoclast generation . Bilezikian J.P., Raisz L.C., Rodan G.A. Principles of bone biology. 1996;1996 Academic, San Diego, CA.
43. Sukhova G.K., Shi G.P., Simon D.I., Chapman H.A., Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 102:1998;576-583.
44. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Mosely J.M., Martin T.J., Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600-2602.
45. Thomas D.M., Udagawa N., Hards D.K., et al. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone. 23:1998;181-186.
46. Udagawa N., Takahashi N., Katagiri T., et al. IL-6 induction of osteoclast differentiation depends upon IL-6 receptors expressed on osteoblastic cells, but not on osteoclast progenitors. J Exp Med. 182:1995;1461-1468.
47. van Hille B., Richener H., Schmid P., Puettner I., Green J.R., Bilbe G. Heterogeneity of vacuolar H(+)-ATPase differential expression of two human subunit B isoforms . Biochem J. 303:1994;191-198.
48. Wang W., Ferguson D.J.P., Quinn J.M.W., Simpson A.H.W., Athanasou N.A. Osteoclasts are capable of both phagocytosis and bone resorption. J Pathol. 182:1997;92-98.
49. Warshawsky H., Goltzman D., Rouleau M.F., Bergeron J.M. Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol. 85:1980;682-694.
50. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.